WisdomTree BioRevolution ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
WisdomTree BioRevolution Fund WDNA
Morningstar’s Analysis WDNA
Will WDNA outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 30.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Twist Bioscience Corp | 5.65 | 146,875 | Healthcare |
Eli Lilly and Co | 4.17 | 108,478 | Healthcare |
Moderna Inc | 3.82 | 99,221 | Healthcare |
Johnson & Johnson | 3.07 | 79,961 | Healthcare |
United Therapeutics Corp | 2.53 | 65,887 | Healthcare |
Immunome Inc Ordinary Shares | 2.47 | 64,282 | Healthcare |
Natera Inc | 2.42 | 62,962 | Healthcare |
Darling Ingredients Inc | 2.33 | 60,513 | Consumer Defensive |
10x Genomics Inc Ordinary Shares - Class A | 2.15 | 55,900 | Healthcare |
Tempus AI Inc Class A common stock | 2.15 | 55,881 | Healthcare |